Why is Hind.Bio Science falling/rising?

As of 17-Sep, Hindustan Bio Sciences Ltd is experiencing a decline in its stock price, currently at 8.05, which reflects a decrease of 0.19 or 2.31%. The stock has underperformed its sector by 2.35% today, and while it is higher than its 5-day moving average, it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable drop in investor participation, with delivery volume falling by 27.74% compared to the 5-day average. Over the past month, the stock has decreased by 6.40%, contrasting with a 2.60% increase in the benchmark index, the Sensex. Year-to-date, the stock is down 21.16%, while the Sensex has risen by 5.83%.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, as indicated by its 1-week return of 2.94% compared to the Sensex's 1.56%. This underperformance, combined with the significant decline in delivery volume and lower investor participation, suggests a lack of confidence among investors. The absence of any positive factors in the dashboard further emphasizes the challenges facing Hindustan Bio Sciences Ltd, contributing to its recent price decline.